Bedfordshire and Luton Joint Prescribing Committee
Ref: JPC Bulletin 279
Bulletin Date: 27/09/19
Review Date: September 2021
Bulletin 279 Umeclidinium / Vilanterol (Anora®Ellipta®) for the treatment of COPD
- The committee agreed to add Umeclidinium / Vilanterol (Anora®Ellipta®) to the formulary within its licensed indication as a 2nd choice LAMA / LABA option for the treatment of COPD.